Aspirin, ibuprofen, and other non-steroidal anti-inflammatory drugs in cancer prevention: a critical review of non-selective COX-2 blockade (review)
about
sameAs
Reduction in the risk of human breast cancer by selective cyclooxygenase-2 (COX-2) inhibitorsSystems psychopharmacology: A network approach to developing novel therapiesCXCR2: a target for pancreatic cancer treatment?Molecular targets of aspirin and cancer prevention.Ovarian epithelial cancer: a role for PGE2-synthesis and signalling in malignant transformation and progressionReduced risk of human lung cancer by selective cyclooxygenase 2 (COX-2) blockade: results of a case control studyUse of non-steroidal anti-inflammatory drugs and prostate cancer risk: a population-based nested case-control studyCanolol inhibits gastric tumors initiation and progression through COX-2/PGE2 pathway in K19-C2mE transgenic miceCyclooxygenase-2 and the inflammogenesis of breast cancer.Inverse association of colorectal cancer prevalence to serum levels of perfluorooctane sulfonate (PFOS) and perfluorooctanoate (PFOA) in a large Appalachian population.Acute effects of prostaglandin E1 and E2 on vascular reactivity and blood flow in situ in the chick chorioallantoic membrane.Pomegranate Extracts in the Management of Men's Urologic Health: Scientific Rationale and Preclinical and Clinical Data.Similar reductions in the risk of human colon cancer by selective and nonselective cyclooxygenase-2 (COX-2) inhibitorsRosiglitazone sensitizes hepatocellular carcinoma cell lines to 5-fluorouracil antitumor activity through activation of the PPARgamma signaling pathwayPhase II, randomized, placebo-controlled trial of neoadjuvant celecoxib in men with clinically localized prostate cancer: evaluation of drug-specific biomarkers.Radiochemistry on electrodes: Synthesis of an 18F-labelled and in vivo stable COX-2 inhibitor.Cancer inflammation and regulatory T cells.Anticancer and cytotoxic properties of the latex of Calotropis procera in a transgenic mouse model of hepatocellular carcinoma.Prescriptions for selective cyclooxygenase-2 inhibitors, non-selective non-steroidal anti-inflammatory drugs, and risk of breast cancer in a population-based case-control studyCancer complicating systemic lupus erythematosus--a dichotomy emerging from a nested case-control study.Non-steroidal anti-inflammatory drug (NSAID) use and breast cancer risk in the Western New York Exposures and Breast Cancer (WEB) Study.Fecal metabolomics: assay performance and association with colorectal cancer.Use of aspirin and other nonsteroidal antiinflammatory medications in relation to prostate cancer riskProstate cancer chemoprevention in men of African descent: current state of the art and opportunities for future research.Apricoxib, a novel inhibitor of COX-2, markedly improves standard therapy response in molecularly defined models of pancreatic cancer.Analgesic use and the risk of kidney cancer: a meta-analysis of epidemiologic studiesEffect of aspirin and other NSAIDs on postmenopausal breast cancer incidence by hormone receptor status: results from a prospective cohort study.Nonsteroidal anti-inflammatory drugs and the risk of Barrett's esophagusContemporary epidemiology of renal cell cancerDiscovering the route from inflammation to pancreatic cancer.Ibuprofen inhibits activation of nuclear {beta}-catenin in human colon adenomas and induces the phosphorylation of GSK-3{beta}.Use of nonsteroidal anti-inflammatory drugs and bladder cancer risk: a meta-analysis of epidemiologic studiesPhospho-ibuprofen (MDC-917) is a novel agent against colon cancer: efficacy, metabolism, and pharmacokinetics in mouse models.Aspirin for the primary prevention of skin cancer: A meta-analysisOncolytic herpes simplex virus 1 encoding 15-prostaglandin dehydrogenase mitigates immune suppression and reduces ectopic primary and metastatic breast cancer in mice.Genetic variation in proinflammatory cytokines IL6, IL6R, TNF-region, and TNFRSF1A and risk of breast cancer.Can daily intake of aspirin and/or statins influence the behavior of non-muscle invasive bladder cancer? A retrospective study on a cohort of patients undergoing transurethral bladder resectionNon-steroidal anti-inflammatory drugs (NSAIDs) and breast cancer risk: differences by molecular subtype.Anticancer activity of fish oils against human lung cancer is associated with changes in formation of PGE2 and PGE3 and alteration of Akt phosphorylationCellular diamine levels in cancer chemoprevention: modulation by ibuprofen and membrane plasmalogens.
P2860
Q25257303-92383F46-1724-48FA-93D9-B3B48398B112Q26750901-01DFA8E7-53B4-4CC3-906E-EA73F3914EEDQ27021588-DE766142-6052-4BD2-AA1C-4F5DD1A4A747Q27687847-3ED113F2-4C79-4D38-9026-6D564F0DABD9Q28210448-5F90AD0A-D814-4160-B7A8-97C46B8BE084Q28217572-F81E58F7-B78A-463A-B762-2FEA8363183DQ28476849-B7D3B744-3F4B-4CC9-910E-F072B28463D2Q28544414-3ACA19C0-28A3-4E86-A71B-17A513AB443EQ30367680-AAFFBC80-72F2-477E-AECB-196A7DFF6321Q30414928-EF0A67F8-6071-4F0F-8409-83A6FD227F48Q30557738-0954BC93-486C-413B-B39D-8826596930D4Q30617117-F6C26757-ED4A-46C1-B6EE-7F7392442D6CQ33360108-EDC343AF-DE7D-4FEC-9AD0-ACC95EDA09FBQ33554975-E0D9CE6E-630E-424A-8A29-A12C4CB7B633Q33561179-C89CAEC3-13F7-410B-9287-EEAD81C6E7A8Q33626578-A46CD177-6B36-4B03-8FC0-8225DBB93CE9Q33796582-9A418DA6-ED49-4F74-98BA-832BF3FAE4E5Q33868476-1148BC6C-6BE0-46E0-841B-C37500DBDF0EQ33889458-7B685FB5-05E4-4883-9A42-EFB5E5701ACDQ33937936-A59F96A2-DAB2-4985-9093-26AF375810C7Q34069337-FBF5BA4C-BA6B-4FCA-98EF-38F00109427AQ34096850-6154A36A-5D57-43E0-AB90-4E6CCAE57A26Q34179634-65E53ED4-D735-4D70-8CEE-207FBF7BFAC3Q34284547-8F6C69A0-0FC6-450A-BB7F-9814A715AC34Q34290118-942CBD28-1BF0-4C51-B52F-A99C78B42E66Q34327296-D1873061-D680-43A2-B9E6-3BE74582D184Q34381496-73C69320-EF7B-40A5-99B4-0F78C2605570Q34429198-890FEA9E-6D1E-4426-A9A1-E6B30E8FB5E4Q34598015-D26E2700-FB2F-4DCE-8ABB-3FF10DC10601Q34645978-2DED7D90-CBFA-4C72-BCEF-FBFD3DCE0BE9Q34808205-97016EEF-0625-44F9-A43F-CA3C051D93A9Q34875118-7D38A2EE-E3AC-4EC3-A669-D04AB8C860EBQ35003113-BA00B588-F888-4B40-9C64-F2C6F19292DEQ35041988-969150BE-F5FC-484E-A12E-DBCDE3BC0EF7Q35077655-DFD32AC4-6AC5-4C3C-B91F-8192768C909EQ35190079-8D669447-49E3-4B2D-BA0D-E2AF804AA2D9Q35204387-A6378621-17B0-4C12-A72E-282DD7C83FE3Q35227086-147EEE37-13F0-4CED-BCA6-263304D65EB8Q35389104-55A05703-7C31-486B-BBC2-8A02C85CFF00Q35595617-D4FF10E5-E4F4-4977-86EA-275DB9DDFB00
P2860
Aspirin, ibuprofen, and other non-steroidal anti-inflammatory drugs in cancer prevention: a critical review of non-selective COX-2 blockade (review)
description
2005 nî lūn-bûn
@nan
2005 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Aspirin, ibuprofen, and other ...... ective COX-2 blockade (review)
@ast
Aspirin, ibuprofen, and other ...... ective COX-2 blockade (review)
@en
Aspirin, ibuprofen, and other ...... ective COX-2 blockade (review)
@nl
type
label
Aspirin, ibuprofen, and other ...... ective COX-2 blockade (review)
@ast
Aspirin, ibuprofen, and other ...... ective COX-2 blockade (review)
@en
Aspirin, ibuprofen, and other ...... ective COX-2 blockade (review)
@nl
prefLabel
Aspirin, ibuprofen, and other ...... ective COX-2 blockade (review)
@ast
Aspirin, ibuprofen, and other ...... ective COX-2 blockade (review)
@en
Aspirin, ibuprofen, and other ...... ective COX-2 blockade (review)
@nl
P2093
P3181
P356
P1433
P1476
Aspirin, ibuprofen, and other ...... ective COX-2 blockade (review)
@en
P2093
Deborah Burr Doss
Joanne Beebe-Donk
Randall E Harris
P304
P3181
P356
10.3892/OR.13.4.559
P407
P577
2005-04-01T00:00:00Z